Bacterial

(2S,5R,6R)-Ticarcillin disodium is a semisynthetic antibiotic that targets bacterial cell wall synthesis, exhibiting bactericidal activity. This compound serves as the (2S,5R,6R)-enantiomer of Ticarcillin, demonstrating efficacy against a broad range of Gram-negative bacteria. It is widely utilized in microbiological research for testing susceptibility and evaluating the mechanisms of antibiotic resistance.

Cetylpyridinium chloride monohydrate is a cationic quaternary ammonium compound that serves as a bacterial inhibitor. It exhibits significant antimicrobial activity, making it effective in preventing plaque formation and reducing gingivitis. This compound is commonly utilized in oral care products, such as mouthwashes and toothpastes, as well as in throat and nasal sprays for its antiseptic properties.

Bacampicillin hydrochloride is a prodrug of ampicillin that acts as a bacterial inhibitor by disrupting cell wall synthesis in susceptible bacteria. It exhibits enhanced oral bioavailability compared to its parent compound, making it a valuable tool in studying bacterial infections and antibiotic resistance. This reagent is applicable in microbiological research and can facilitate investigations into the efficacy of penicillin derivatives in various laboratory settings.

Benzalkonium chloride (51% in water) is a widely utilized bacterial inhibitor that acts by disrupting microbial cell membranes. This potent antimicrobial agent is commonly deployed in various applications, including as a preservative in ophthalmic formulations, such as eye drops. Its effectiveness against a broad spectrum of bacteria makes it an essential reagent for research and development in microbiology and pharmaceutical studies.

Isoniazid is a prodrug that targets the bacterial enzyme catalase-peroxidase (KatG) for activation, leading to its bactericidal effects against rapidly dividing mycobacteria. This compound exhibits significant anti-tuberculostatic activity and is widely used in research focused on tuberculosis and other mycobacterial infections. Its mechanism of action makes it a valuable reagent for investigating bacterial resistance and developing novel therapeutic strategies.

Ethambutol is an antimycobacterial agent that targets arabinosyltransferase, inhibiting cell wall synthesis in bacteria. This compound is primarily utilized in research related to mycobacterial infections and has applications in developing animal models for conditions such as hyperuricemia and optic neuropathy. Ethambutol's ability to interrupt bacterial growth makes it valuable for studying microbial pathogenesis and treatment strategies.

Puromycin is an aminoglycoside antibiotic that functions as a protein synthesis inhibitor through its action on bacterial ribosomes. By mimicking aminoacyl-tRNA, puromycin interferes with the elongation step of translation, leading to the premature termination of peptide chains. This compound is widely utilized in molecular biology studies, particularly in selection and maintenance of genetically modified cells, as well as in cancer research to elucidate apoptosis pathways.

3,5,4'-Tribromosalicylanilide is a bacterial inhibitor that exhibits potent antituberculosis activity. This compound effectively inhibits the growth of Mycobacterium tuberculosis and Mycobacterium abscessus, demonstrating its potential in combating mycobacterial infections. Additionally, it influences gene expression, suggesting its utility in research focused on antibiotic resistance and microbial gene regulation.

Benzoyleneurea is a bacterial inhibitor that demonstrates significant anti-bacterial activity. This compound serves as a valuable scaffold for the development of novel protein geranylgeranyltransferase-I (PGGTase-I) inhibitors, making it a useful tool in antibiotic research and drug discovery aimed at combating bacterial infections.

Tenuazonic acid is a mycotoxin belonging to the tetramic acids family, functioning primarily as an inhibitor of bacterial protein biosynthesis by promoting the suppression of new protein release on ribosomes. It exhibits acute toxicity, with oral LD50 values ranging between 81-186 mg/kg in rodents. Tenuazonic acid also acts as a photosystem II inhibitor by preventing electron transport beyond the primary quinone receptor (QA) through its interaction with the D1 protein. Furthermore, this compound has demonstrated antiviral activity against various viruses, including measles and respiratory viruses, and exhibits potential inhibitory effects on skin cancer.